Total-Body Irradiation and Chemotherapy Followed By Donor Bone Marrow Transplant in Treating Young Patients With Hematologic Cancer

NCT00028730 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Leukemia
Lymphoma
Myelodysplastic Syndromes
Myelodysplastic/Myeloproliferative Neoplasms

Interventions

BIOLOGICAL: anti-thymocyte globulin
BIOLOGICAL: filgrastim
DRUG: cyclophosphamide
DRUG: fludarabine phosphate
DRUG: thiotepa
PROCEDURE: allogeneic bone marrow transplantation
RADIATION: radiation therapy

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]